‘Anger Management’ Casting ‘Sexy’ New Co-Star For Charlie Sheen: Will Mila Kunis Join Season 2?
FX’s situation comedy “Anger Management” is wasting no time in replacing Selma Blair. The Charlie Sheen vehicle is currently looking to cast a “sexy” new actress to fill the void Blair left after being fired last week.
According to Entertainment Weekly, the “Anger Management” casting director is looking for a new doctor, although that doctor does not have a name yet. The potential actress must be “gorgeous,” “sexy,” in her 30s or 40s, Latina or Caucasian, and between 5 feet and 5 feet 6 inches tall.
“If Charlie and Kate were like Sam and Diane on Cheers, then you are Rebecca,” the casting description reads. “Tough, career driven, neurotic and you wear your heart on your sleeve ... and you hate yourself for eventually becoming attracted to Charlie.”
The untitled character would pick up right where Blair’s Kate left off, helping Charlie co-author sex research that Charlie’s character had been working on. Although the “Anger Management” production company, Lionsgate, told EW that the new casting description is just “exploratory” and not definite, Sheen already has someone in mind for the role: Mila Kunis.
Rumors are circulating that Sheen wants Kunis, who just happens to be the girlfriend of his “Two and a Half Men” successor, Ashton Kutcher. An insider is claiming the actor is willing to offer the 29-year-old “That ’70s Show” actress a 10-episode arc at a cool $1 million per episode. “Anger Management” has neither confirmed nor denied the supposed offer, and Kunis has not released a statement about it.
TMZ first reported the news that Sheen had fired Blair after learning she complained to the show’s executives about her co-star’s unprofessional behavior. Sheen allegedly thought that Blair was out of line and reportedly refused to work if Blair showed up on the set.
On June 18, Lionsgate released an official statement confirming that Blair would not be returning to the FX series. “We wish her the very best,” it concluded in the statement.
© Copyright IBTimes 2024. All rights reserved.